An integrated computational approach to infer therapeutic targets from Campylobacter concisus and peptidomimetic based inhibition of its pyrimidine metabolism pathway

References

• Aabenhus, R., On, S. L., Siemer, B. L., Permin, H., & Andersen, L. P. (2005). Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data. Journal of Clinical Microbiology, 43(10), 5091–5096. https://doi.org/10.1128/JCM.43.10.5091-5096.2005
   PubMed Web of Science ®Google Scholar
• Alfredson, D. A., & Korolik, V. J. F. (2007). Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiology Letters, 277(2), 123–132.
   PubMed Web of Science ®Google Scholar
• Arafat, M., Sarfraz, M., & AbuRuz, S. (2021). Development and in vitro evaluation of controlled release Viagra® containing poloxamer-188 using Gastroplus™ PBPK modeling software for in vivo predictions and pharmacokinetic assessments. Pharmaceuticals, 14(5), 479. https://doi.org/10.3390/ph14050479
   Web of Science ®Google Scholar
• Basharat, Z., Akhtar, U., Khan, K., Alotaibi, G., Jalal, K., Abbas, M. N., Hayat, A., Ahmad, D., & Hassan, S. S. (2022). Differential analysis of Orientia tsutsugamushi genomes for therapeutic target identification and possible intervention through natural product inhibitor screening. Computers in Biology and Medicine, 141, 105165. https://doi.org/10.1016/j.compbiomed.2021.105165
   PubMed Web of Science ®Google Scholar
• Basharat, Z., Jahanzaib, M., & Rahman, N. (2021). Therapeutic target identification via differential genome analysis of antibiotic resistant Shigella sonnei and inhibitor evaluation against a selected drug target. Infection, Genetics and Evolution, 94, 105004. https://doi.org/10.1016/j.meegid.2021.105004
   PubMed Web of Science ®Google Scholar
• Basharat, Z., Khan, K., Jalal, K., Ahmad, D., Hayat, A., Alotaibi, G., Al Mouslem, A., Aba Alkhayl, F. F., Almatroudi, A. (2022). An in silico hierarchal approach for drug candidate mining and validation of natural product inhibitors against pyrimidine biosynthesis enzyme in the antibiotic-resistant Shigella flexneri. Infection Genetics and Evolution, 98, 105233.
   Google Scholar
• Batz, M. B., Hoffmann, S., & Morris, J. G., Jr. (2012). Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. Journal of Food Protection, 75(7), 1278–1291. https://doi.org/10.4315/0362-028X.JFP-11-418
   PubMed Web of Science ®Google Scholar
• Chakrabarty, R. P., Alam, A. R. U., Shill, D. K., & Rahman, A. (2020). Identification and qualitative characterization of new therapeutic targets in Stenotrophomonas maltophilia through in silico proteome exploration. Microbial Pathogenesis, 149, 104293. https://doi.org/10.1016/j.micpath.2020.104293
   PubMed Web of Science ®Google Scholar
• Chen, Y., & Ung, C. (2001). Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand–protein inverse docking approach. Journal of Molecular Graphics and Modelling, 20(3), 199–218. https://doi.org/10.1016/S1093-3263(01)00109-7
   PubMed Web of Science ®Google Scholar
• Daga, P. R., Bolger, M. B., Haworth, I. S., Clark, R. D., & Martin, E. J. (2018). Physiologically based pharmacokinetic modeling in lead optimization. 1. Evaluation and adaptation of GastroPlus to predict bioavailability of medchem series. Molecular Pharmaceutics, 15(3), 821–830. https://doi.org/10.1021/acs.molpharmaceut.7b00972
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Del Gatto, A., Cobb, S. L., Zhang, J., & Zaccaro, L. (2021). Editorial: Peptidomimetics: Synthetic tools for drug discovery and development. Frontiers in Chemistry, 9, 802120. https://doi.org/10.3389/fchem.2021.802120
   PubMed Web of Science ®Google Scholar
• Eisenberg, D., Luthy, R., & Bowie, J. U. (1997). VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology, 277, 396–404. https://doi.org/10.1016/s0076-6879(97)77022-8
   PubMed Web of Science ®Google Scholar
• Garrity, G., Brenner, D., Krieg, N., & Staley, J. (2005). Genus I. Campylobacter. In Bergey’s manual of systematic bacteriology. Springer.
   Google Scholar
• Geissler, B., Shiomi, D., & Margolin, W. J. M. (2007). The ftsA* gain-of-function allele of Escherichia coli and its effects on the stability and dynamics of the Z ring. Microbiology, 153(Pt 3), 814.
   Google Scholar
• Hall, A. J., Wikswo, M. E., Manikonda, K., Roberts, V. A., Yoder, J. S., & Gould, L. H. (2013). Acute gastroenteritis surveillance through the national outbreak reporting system, United States. Emerging Infectious Diseases, 19(8), 1305.
   PubMed Web of Science ®Google Scholar
• Honório, T. d. S., Pinto, E. C., Rocha, H. V. A., Esteves, V. S. A. D., dos Santos, T. C., Castro, H. C. R., Rodrigues, C. R., de Sousa, V. P., & Cabral, L. M. (2013). In vitro–in vivo correlation of efavirenz tablets using GastroPlus®. AAPS PharmSciTech, 14(3), 1244–1254.
   PubMed Web of Science ®Google Scholar
• Huq, M., & Istivan, T. (2021). Conventional and molecular detection methods of the opportunistic bacterial pathogen Campylobacter concisus campylobacter. IntechOpen.
   Google Scholar
• Hussain, A., Altamimi, M. A., Alshehri, S., Imam, S. S., & Singh, S. K. (2020). Vesicular elastic liposomes for transdermal delivery of rifampicin: In-vitro, in-vivo and in silico GastroPlus™ prediction studies. European Journal of Pharmaceutical Sciences, 151, 105411. https://doi.org/10.1016/j.ejps.2020.105411
   PubMed Web of Science ®Google Scholar
• Iovine, N. M. (2013). Resistance mechanisms in Campylobacter jejuni. Virulence, 4(3), 230–240.
   PubMed Web of Science ®Google Scholar
• Istivan, T. S., Coloe, P. J., Fry, B. N., Ward, P., & Smith, S. C. J. J. (2004). Characterization of a haemolytic phospholipase A2 activity in clinical isolates of Campylobacter concisus. Journal of Medical Microbiology, 53(6), 483–493.
   Google Scholar
• Jalal, K., Khan, K., Hassam, M., Abbas, M. N., Uddin, R., Khusro, A., … Gajdács, M. J. M. (2021). Identification of a novel therapeutic target against XDR Salmonella typhi H58 using genomics driven approach followed up by natural products virtual screening. Microorganisms, 9(12), 2512.
   Google Scholar
• Johansson, E., Fanø, M., Bynck, J. H., Neuhard, J., Larsen, S., Sigurskjold, B. W., Christensen, U., & Willemoës, M. (2005). Structures of dCTP deaminase from Escherichia coli with bound substrate and product: Reaction mechanism and determinants of mono- and bifunctionality for a family of enzymes. The Journal of Biological Chemistry, 280(4), 3051–3059.
   PubMed Web of Science ®Google Scholar
• Kaakoush, N. O., Castaño-Rodríguez, N., Mitchell, H. M., & Man, S. M. (2015). Global epidemiology of Campylobacter infection. Clinical Microbiology Reviews, 28(3), 687–720.
   PubMed Web of Science ®Google Scholar
• Kaakoush, N. O., & Mitchell, H. M. J. F. (2012). Campylobacter concisus – A new player in intestinal disease. Frontier in Cellular and Infection Microbiology, 2, 4.
   Google Scholar
• Kandeel, M., & Al-Taher, A. J. P. V. J. (2021). Molecular landscapes of deoxyuridine 5′-triphosphatase (dUTPase) as a drug target against camel Trypanosoma evansi. Pakistan Veterinary Journal, 41(2), 235–241.
   Google Scholar
• Kirk, K. F., Nielsen, H. L., Thorlacius-Ussing, O., & Nielsen, H. (2016). Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease. Gut Pathogens, 8(1), 1–6.
   PubMedGoogle Scholar
• Kotloff, K. L., Nataro, J. P., Blackwelder, W. C., Nasrin, D., Farag, T. H., Panchalingam, S., … Breiman, R. F. (2013). Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. The Lancet, 382(9888), 209–222.
   PubMed Web of Science ®Google Scholar
• Kumar, S., & Ramanujam, M. (2020). Computational prediction of novel broad-spectrum drug targets against vibrio cholerae by integrated genomics and proteomics approach. Malysian Journal of Medical and Health Sciences, 16(2), 99–104.
   Google Scholar
• Lastovica, A. J., On, S., & Zhang, L. (2014). The family Campylobacteraceae. Springer-Verlag.
   Google Scholar
• Li, W., & Godzik, A. J. B. (2006). Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics (Oxford, England), 22(13), 1658–1659.
   PubMed Web of Science ®Google Scholar
• Little, C., Gormley, F., Rawal, N., & Richardson, J. (2010). A recipe for disaster: Outbreaks of Campylobacteriosis associated with poultry liver pâté in England and Wales. Epidemiology and Infection, 138(12), 1691–1694.
   PubMed Web of Science ®Google Scholar
• Liu, F., Ma, R., Tay, C. Y. A., Octavia, S., Lan, R., … Chung, H. K. L. (2018). Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active crohn’s disease. Emerging Microbes & Infections, 7(1), 1–14.
   Google Scholar
• Liu, F., Ma, R., Wang, Y., & Zhang, L. (2018). The clinical importance of Campylobacter concisus and other human hosted Campylobacter species. Frontiers in Cellular and Infection Microbiology, 8, 243.
   PubMed Web of Science ®Google Scholar
• Liu, S., Wang, S.-X., Liu, W., Wang, C., Zhang, F.-Z., Ye, Y.-N., … Guo, F.-B J. D. (2020). CEG 2.0: An updated database of clusters of essential genes including eukaryotic organisms. 2020.
   Google Scholar
• Lock, R. L., & Harry, E. J. (2008). Cell-division inhibitors: New insights for future antibiotics. Nature Reviews Drug Discovery, 7(4), 324–338.
   PubMed Web of Science ®Google Scholar
• Luo, H., Lin, Y., Liu, T., Lai, F.-L., Zhang, C.-T., Gao, F., & Zhang, R. (2021). DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools. Nucleic Acids Research, 49(D1), D677–D686.
   PubMed Web of Science ®Google Scholar
• Mahendran, V., Riordan, S. M., Grimm, M. C., Tran, T. A. T., Major, J., Kaakoush, N. O., … Zhang, L. (2011). Prevalence of Campylobacter species in adult Crohn’s disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One, 6(9), e25417.
   PubMed Web of Science ®Google Scholar
• Marshall, G. R., & Ballante, F. (2017). Limiting assumptions in the design of peptidomimetics. Drug Development Research, 78(6), 245–267. https://doi.org/10.1002/ddr.21406
   PubMed Web of Science ®Google Scholar
• Mukhopadhya, I., Thomson, J. M., Hansen, R., Berry, S. H., El-Omar, E. M., & Hold, G. L. (2011). Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One, 6(6), e21490.
   PubMed Web of Science ®Google Scholar
• Naorem, R. S., Pangabam, B. D., Bora, S. S., Goswami, G., Barooah, M., Hazarika, D. J., & Fekete, C. (2022). Identification of putative vaccine and drug targets against the methicillin-resistant staphylococcus aureus by reverse vaccinology and subtractive genomics approaches. Molecules, 27(7), 2083.
   PubMed Web of Science ®Google Scholar
• Nielsen, H. L., Ejlertsen, T., Engberg, J., & Nielsen, H. (2013). High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: A population-based study. Clinical Microbiology and Infection, 19(5), 445–450.
   PubMed Web of Science ®Google Scholar
• Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019). e toxpred: A machine learning-based approach to estimate the toxicity of drug candidates. BMC Pharmacology and Toxicology, 20(1), 1–15.
   PubMedGoogle Scholar
• Rahman, N., Basharat, Z., Yousuf, M., Castaldo, G., Rastrelli, L., & Khan, H. (2020). Virtual screening of natural products against type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2). Molecules, 25(10), 2271. https://doi.org/10.3390/molecules25102271
   Web of Science ®Google Scholar
• Rytkonen, J., Ranta, V. P., Kokki, M., Kokki, H., Hautajarvi, H., Rinne, V., & Heikkinen, A. T. (2020). Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions. Biopharmaceutics & Drug Disposition, 41(1–2), 72–88. https://doi.org/10.1002/bdd.2215
   PubMed Web of Science ®Google Scholar
• Schuldt, L., Weyand, S., Kefala, G., & Weiss, M. S. (2009). The three-dimensional structure of a mycobacterial DapD provides insights into DapD diversity and reveals unexpected particulars about the enzymatic mechanism. Journal of Molecular Biology, 389(5), 863–879.
   PubMed Web of Science ®Google Scholar
• Sheik, S. S., Sundararajan, P., Hussain, A. S., & Sekar, K. (2002). Ramachandran plot on the web. Bioinformatics (Oxford, England), 18(11), 1548–1549. https://doi.org/10.1093/bioinformatics/18.11.1548
   PubMed Web of Science ®Google Scholar
• Tanner, A. C., Badger, S., Lai, C.-H., Listgarten, M. A., Visconti, R. A., & Socransky, S. S. (1981). Wolinella gen. nov., Wolinella succinogenes (Vibrio succinogenes Wolin et al.) comb. nov., and description of Bacteroides gracilis sp. nov., Wolinella recta sp. nov., Campylobacter concisus sp. nov., and Eikenella corrodens from humans with periodontal disease. International Journal of Systematic and Evolutionary Microbiology, 31(4), 432–445.
   Google Scholar
• Tistaert, C., Heimbach, T., Xia, B., Parrott, N., Samant, T. S., & Kesisoglou, F. (2019). Food effect projections via physiologically based pharmacokinetic modeling: Predictive case studies. Journal of Pharmaceutical Sciences, 108(1), 592–602. https://doi.org/10.1016/j.xphs.2018.05.024
   PubMed Web of Science ®Google Scholar
• Vandamme, P. (2005). Genus I. Campylobacter Sebald and Veron 1963, 907, AL emend. Vandamme, Falsen, Rossau, Hoste, Segers, Tytgat, De Ley 1991a, 98. Bergey’s Mannual of Systematic Bacteriology, 2, 1147–1160.
   Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., … Sayeeda, Z. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082.
   PubMed Web of Science ®Google Scholar
• Yeow, M., Liu, F., Ma, R., Williams, T. J., Riordan, S. M., & Zhang, L. (2020). Analyses of energy metabolism and stress defence provide insights into Campylobacter concisus growth and pathogenicity. Gut Pathogens, 12(1), 1–13.
   PubMed Web of Science ®Google Scholar